The FDA’s Gastroenterology-Urology Devices Panel voted unanimously that LINX’s Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a ...

One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...

FDA has announced it has approved Torax Medical’s LINX Reflux Management System for treatment of gastroesophageal reflux disease, according to a news release. The LINX Reflux Management System is a ...

(Reuters) -Johnson & Johnson said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial reasons. The company has decided ...

Johnson & Johnson (NYSE:JNJ) will withdraw its LINX Reflux Management System—a device used to treat acid reflux disease—from markets outside the U.S. from March, according to a Bloomberg report that ...

Johnson & Johnson (NYSE:JNJ) is one of the best conservative stocks to buy now. On September 23, the company announced plans to withdraw the LINX Reflux Management System in certain countries. The ...